| Literature DB >> 20808759 |
Agnès Fleury1, Jael Moreno García, Paulina Valdez Aguerrebere, María de Sayve Durán, Paola Becerril Rodríguez, Carlos Larralde, Edda Sciutto.
Abstract
BACKGROUND: The ongoing epidemiological transition in Mexico minimizes the relative impact of neurocysticercosis (NC) on public health. However, hard data on the disease frequency are not available.Entities:
Mesh:
Year: 2010 PMID: 20808759 PMCID: PMC2927420 DOI: 10.1371/journal.pntd.0000805
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Clinical features of NC patients in 1994 and 2004.
| 1994 | 2004 | P | |
| NC frequency | 2.4 (2.0–2.9) | 2.5 (2.1–3.0) | 0.74 |
| Age (years)‡ | 38.1 (35.5–40.8) | 38.8 (36.2–41.5) | 0.72 |
| Sex (% Male) | 53 (42.7–63.1) | 51.7 (42.4–60.9) | 0.84 |
| City of origin (% Mexico City) | 20 (0.13–0.29) | 37.5 (0.29–0.47) | 0.005 |
| Symptoms at diagnosis | |||
| Headache | 12 (6.3–20) | 18.3 (11.8–26.4) | 0.2 |
| Seizures | 36 (26.6–46.2) | 35.8 (27.2–45.0) | 0.98 |
| Intracranial hypertension | 45 (35.1–55.3) | 27.5 (19.7–36.4) | 0.007 |
| Radiological picture | |||
| Parasite viability (% viable) | 56.7 (46.2–66.7) | 59.6 (50.1–68.7) | 0.66 |
| number (% multiple) | 58.8 (48.3–68.7) | 63.2 (53.6–72.0) | 0.51 |
| localization (% SAb or V) | 55.7 (45.2–65.8) | 45.6 (36.3–55.2) | 0.14 |
| Cellularity of CSF (cells/mm3) ‡,
| 24.5 (12.1–36.9) | 26.5 (16.4–36.5) | 0.80 |
All values are proportions and expressed as percentages, unless designated as a mean(‡). 95% confidence intervals are presented in parentheses.
*: 9 patients did not harbor a cysticercus at the time of diagnosis in INNN, some of them only showed arachnoiditis and others had been treated before in other hospitals.
**: SAb: SubArachnoidal space of the base of the skull/V: Ventricular/P: Parenchymal/Sas: SubArachnoidal space of the sulci.
***: Lumbar puncture was performed at time of diagnosis in only 79 NCC patients in 1994, and in 79 patients in 2004.
Figure 1Annual frequencies of hospitalized NC patients (INNN, 1995–2009).